mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
6e-10 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.24 |
7e-06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |